Market Currents
Galena Biopharma (GALE) +11.7% premarket on news of the issuance of a key patent covering the...
-
Wednesday, July 18, 2012, 9:19 AM ETGalena Biopharma (GALE) +11.7% premarket on news of the issuance of a key patent covering the use of its NeuVax product candidate for breast cancer patients having low-to-intermediate IHC levels, which represent a significant unmet medical need with as much as 80% of patients who do not qualify for Herceptin therapy.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
